Novel function of lymphotoxin in mucosal immunity

December 11, 2013

This study was initiated almost 10 years ago, even before our group has moved to Berlin, says Sergei Nedospasov, the senior author of the study. We have generated a panel of mice with ablation of TNF, LTα and LTβ in various types of cells, and noted anatomic phenotypes in mice which lacked one of these three genes in RORγt+ ILC. These partial knockouts recapitulated defects in lymphoid organs development, including Peyer's patches (PP), in mice with complete knockouts of the same genes.

When in 2007 our group was invited to join Sonderforschungsbereich (SFB) 633, funded by the German Science Foundation (DFG), which is focusing on mucosal immunity, we thought that we had a good model system in hand to address the mechanisms of immunity in the absence of organized lymphoid tissues in the gut. Surprisingly, mice with ablation of membrane-bound lymphotoxin β (LTα1β2) produced by RORγt+ ILC were still able to mount normal IgA levels in the lamina propria, in spite of the absence of PP and isolated lymphoid follicles.

However, the most interesting result was obtained in mice with ablation of LTα in RORγt+ cells – such animals showed abrogated IgA production in the gut and grossly altered microbiota composition. This study may change the existing paradigm for T-cell-dependent and T-cell-independent pathways in the contol of IgA production in the gut. For cytokine experts it will be interesting to learn about distinct TNF-like function of soluble sLTα in vivo, as the controversy about biological functions of this particular form of lymphotoxin has been going on for over 20 years.

Although this study was done in mice and not in patients, the discovery reported in Science may be of relevance for anti-TNF therapy using Etanercept, as this drug can block not only TNF but also soluble lymphotoxin. It would be interesting now to evaluate possible effects of such treatment on IgA levels and in patients, especially because Etanercept, unlike other anti-TNF drugs, is ineffective in .

The German Rheumatism Research Centre (DRFZ) Berlin, a Leibniz Instiute, investigates rheumatic diseases in an interdisciplinary manner. 25 research groups study immunology, experimental rheumatology and epidemiology of . A hallmark of the DRFZ is the close connection to the Charité - Universitätsmedizin Berlin. A benefit for both physicians and scientists: this unique setting enables the development of experimental research to meet the clinical challenges and the application of modern technologies and methods in the clinic.

Explore further: New insights into the immune system of the gastrointestinal tract

More information: Kruglov, A. et al. (2013), Nonredundant Function of Soluble LTa3 Produced by Innate Lymphoid Cells in Intestinal Homeostasis. Science, DOI: 10.1126/science.1243364

Related Stories

New insights into the immune system of the gastrointestinal tract

December 9, 2013
Lymphotoxin is a cytokine, or intercellular messenger, and plays an important role in the immunological balance of the gastrointestinal tract. It regulates the immune system of the digestive tract, which is made up of immune ...

Bacteria tails implicated in gut inflammation

December 11, 2013
In healthy individuals, the only thing that separates the lining of the human gut from the some 100 trillion bacterial cells in the gastrointestinal tract is a layer of mucous.

New technique allows anti-breast cancer drugs to cross blood-brain barrier

October 9, 2013
Some breast cancer drugs can penetrate the blood-brain barrier (BBB), but they have not been very effective against brain metastases, whereas other, more effective anti-breast cancer drugs cannot penetrate the BBB at all. ...

Target for new Rx class for inflammatory disorders discovered

October 3, 2013
Research led by Charles Nichols, PhD, Associate Professor of Pharmacology at LSU Health Sciences Center New Orleans, describes a powerful new anti-inflammatory mechanism that could lead to the development of new oral medications ...

Gut microbes affect MicroRNA response to bacterial infection

December 10, 2013
When it comes to fighting off pathogens like Listeria, your best allies may be the billions of microorganisms that line your gut, according to new research published in mBio, the online open-access journal of the American ...

Research shows how immune system peacefully co-exists with 'good' bacteria

May 22, 2013
The human gut is loaded with commensal bacteria – "good" microbes that, among other functions, help the body digest food. The gastrointestinal tract contains literally trillions of such cells, and yet the immune system ...

Recommended for you

Genetic immune deficiency could hold key to severe childhood infections

July 18, 2017
A gene mutation making young children extremely vulnerable to common viruses may represent a new type of immunodeficiency, according to a University of Queensland researcher.

What are the best ways to diagnose and manage asthma?

July 18, 2017
What are the best ways to diagnose and manage asthma in adults? This can be tricky because asthma can stem from several causes and treatment often depends on what is triggering the asthma.

Study finds molecular explanation for struggles of obese asthmatics

July 17, 2017
A large, bouquet-shaped molecule called surfactant protein A, or SP-A, may explain why obese asthma patients have harder-to-treat symptoms than their lean and overweight counterparts, according to a new study led by scientists ...

Large multi-ethnic study identifies many new genetic markers for lupus

July 17, 2017
Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus.

Team identifies potential cause for lupus

July 14, 2017
Leading rheumatologist and Feinstein Institute for Medical Research Professor Betty Diamond, MD, may have identified a protein as a cause for the adverse reaction of the immune system in patients suffering from lupus. A better ...

Immunosuppression underlies resistance to anti-angiogenic therapy

July 14, 2017
A Massachusetts General Hospital (MGH) research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels. In their report ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.